Abstract
In addition to polypeptide growth factors, an emerging group of naturally occurring phospholipid growth factors has been discovered1. Within this group, lysophosphatidic acid (LPA, l-acyl-2-lyso-sn-glycero-3-phosphate), nature’s simplest phospholipid, was found to elicit growth factory-like effects in almost every cell type spanning the phylogenetic tree, from Dictyostelium to humans. These biological effects include: 1) the mitogenic2 or antimitogenic regulation of the cell cycle3, 2) regulation of Ca2+ homeostasis4. 3) regulation of cell shape5, migration6, and tumor cell invasiveness7, and 4) the prevention of apoptosis8. LPA elicits these effects via multiple G protein-coupled receptors. Here we report that naturally occurring analogs of LPA elicit distinct cellular responses via the selective activation of receptor subligand specificities towards LPA, cyclic-phosphatidic acid (cyclic-PA), and plasmalogenglycerophosphate (alkenyl-GP).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Refferences
A. Tokumura. A family of phospholipid autacoids: Occurrence, metabolism, and bioactions. Prog. Lipid. Res.34:151 (1995).
E.J. van Corven, A. Groenink, K. Jalink, T. Eichholtz, and W.H. Moolenar. Lysophosphatidic acid-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins. Cell 59:45(1989).
G. Tigyi, D. Dyer, and R. Miledi. Lysophosphatidic acid possesses dual action in cell proliferation. Proc. Nat. Acad. Sci. USA 91:1908 (1994).
G. Tigyi and R. Miledi. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopusoocytes and neurite retraction in PC12 pheochromocytoma cells. J. Biol. Chem. 267:21360 (1992).
G. Tigyi, D. Fischer, C. Yang, D. Dyer, A. Sebok, and R. Miledi. Lysophosphatidic acid-induced neurite retraction in PC12 cells: Conrol by phosphoinositide-Ca2+ signaling and Rho. J. Neurochem.66:537 (1996).
D. Zhou, W. Luini, S. Bernasconi, L. Diomede, M. Salmona, A. Mantovani, and S. Sozzani. Phosphatidic acid and lysophosphatidic acid induce heptotactic migration of human monocytes. J. Biol. Chem.270:25549 (1995).
F. Imamura, T. Horai, M. Mukai, K. Shinkai, M. Sawada, and H. Akedo. Inductin of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun.193:497 (1993).
S.R. Umansky, J.P. Shapiro, G.M. Cuenco, W.M. Foehr, I.C. Bathurst, and L.D. Tomei. Prevention of rat neonatal cardiomyocyte apoptosis induced by stimulated in vitro ischemia and reperfusion. Cell Ceath Diff.4:608 (1997).
K. Liliom, D.J. Fischer, G. Sun, D.D. Miller, J.L. Tseng, D.M. Desiderio, M.C. Seidel, J.R. Erickson, and G. Tigyi. Identificatin of a novel growth factor-like lipid: 1-O-cis-alk-l—-enyl-21yso-sn-glycero-3-phosphage (Alkenyl-GP) that is present in commercial sphingolipid preparations. J. Biol. Chem.273:in press (1998).
K. Lilion, Z. guan, J.L. Tseng, D.M. Desiderio, G. Tigyi, and M. Watsky. Growth factor-like phospholipids generated following corneal injury. Am. J. Physiol.(Cell Physiol. 43) 274:in press (1998).
K. Murakami-Murofushi, K. Kaji, K. Kano, M. Fukuda, M. Shioda, and H. Murofushi. Inhibition of cell proliferation by a unique lysophosphatidic acid, PHYLPA, isolated from Physarum polycephalum:signaling events of antiproliferative action by PHYLPA. Cell Struct. Funct. 18:363 (1993).
W.H. Moolenaar, O. Kranenburg, F.R. Postma, and G. Zondag. Lysophosphatidic acid: G protein signaling and cellular responses. Curr. Opin. Cell Biol.9:168 (1997).
Z. Guo, K. Lilion, D.J. Fischer, I.C. Bathurst, D.J. tomei, M.C. Kiefer, and G. Tigyi. Molecular cloning of a h igh affinity receptor for the growth factory-like phospholipid mediator lysophosphatidic acid. Proc. Natl. Acad. Sci. USA93:14367(1996).
J. H. Hecht, J.A. Weiner, S.R. Pots, and J. Chun. Vzg-1 encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell. Biol.135:1071 (1996).
J. R. Erickson, J.J. Wu, G. Goddard, K. Kawanishi, G. Tigyi, L.D. Tomei, and M.C. Kiefer. The putative lysophosphatidic acid receptor Edg-2/Vzg-1 functionally couples to the yeast response pathway. J. Biol. Chem.273:1506 (1998).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tigyi, G. et al. (1999). Determinants of Receptor Subtype Specificity in the LPA-Like Lipid Mediator Family. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E.A. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 4. Advances in Experimental Medicine and Biology, vol 469. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4793-8_36
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4793-8_36
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7171-7
Online ISBN: 978-1-4615-4793-8
eBook Packages: Springer Book Archive